Tagged: 'Avidity Biosciences'

So rather than several months it took just several weeks (well around six weeks) for Swiss pharmaceutical giant Novartis to return with a proper takeover offer for Avidity Biosciences, the US-listed biotechnology company.

Back in early August hacks at the Financial Times ran with the Avidity Biosciences takeover rumour that was circulating European markets.

Some investors were a little disappointed to see news this morning about Novartis's $1.4 billion takeover of US-listed biopharmaceutical company Tourmaline Bio.

Hacks at the Financial Times have decided to run the Avidity Biosciences takeover tale that has been circulating around for the last couple of weeks.